J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

NSE:JBCHEPHARM Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 28, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	277,332	252,540	255,986	152,503	121,735	96,881
Market Cap Growth	-3.88%	-1.35%	67.86%	25.27%	25.65%	146.60%
Enterprise Value	271,800	249,373	256,557	154,282	114,656	92,331
Last Close Price	1771.30	1616.90	1630.17	969.41	765.77	604.39
PE Ratio	38.61	38.29	46.32	37.21	31.59	21.63
PS Ratio	6.78	6.45	7.35	4.84	5.02	4.74
PB Ratio	7.29	7.36	8.76	6.15	5.69	5.34
P/TBV Ratio	11.20	12.27	17.33	13.86	8.66	5.63
P/FCF Ratio	35.60	31.38	37.99	27.42	113.49	36.28
P/OCF Ratio	31.26	27.98	31.97	24.26	71.55	30.78
EV/Sales Ratio	6.64	6.37	7.36	4.90	4.73	4.52
EV/EBITDA Ratio	24.94	24.48	29.11	21.92	21.29	16.79
EV/EBIT Ratio	29.70	29.00	34.01	26.07	24.19	18.86
EV/FCF Ratio	34.89	30.98	38.08	27.74	106.89	34.58
Debt / Equity Ratio	0.01	0.01	0.13	0.23	0.03	0.03
Debt / EBITDA Ratio	0.04	0.03	0.42	0.81	0.10	0.08
Debt / FCF Ratio	0.05	0.04	0.56	1.03	0.51	0.17
Asset Turnover	0.94	0.95	0.92	1.02	1.00	1.01
Inventory Turnover	2.44	2.63	2.60	2.85	2.29	2.32
Quick Ratio	2.27	2.02	1.34	1.57	1.70	3.22
Current Ratio	3.79	3.04	2.13	2.76	3.27	4.50
Return on Equity (ROE)	20.47%	20.75%	20.45%	17.75%	19.54%	27.59%
Return on Assets (ROA)	13.09%	13.00%	12.49%	12.01%	12.22%	15.08%
Return on Capital (ROIC)	15.98%	15.90%	14.84%	14.10%	14.62%	18.37%
Return on Capital Employed (ROCE)	22.70%	23.60%	24.10%	19.70%	21.30%	25.90%
Earnings Yield	2.59%	2.61%	2.16%	2.69%	3.17%	4.62%
FCF Yield	2.81%	3.19%	2.63%	3.65%	0.88%	2.76%
Dividend Yield	0.87%	0.96%	0.75%	0.92%	1.08%	1.36%
Payout Ratio	33.64%	35.94%	28.41%	31.13%	33.10%	16.35%
Buyback Yield / Dilution	0.27%	-0.07%	-1.26%	-1.23%	-0.10%	2.86%
Total Shareholder Return	1.14%	0.89%	-0.51%	-0.32%	0.98%	4.22%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.